FilingSEC EDGAR8-K
Intelligent Bio Solutions Reports 2026 Fiscal Year Revenue of $4.2 Million, Up 38%
· SEC accepted
StageResults
Filing content
Intelligent Bio Solutions reported $4.2 million in revenue for fiscal year 2026, a 38% increase, and continues to progress through the FDA regulatory process.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…